BIOMAT Database Logo BIOMAT Database Logo

[Diagnostic importance of fibrinogen degradation products in viral hepatitis]. 1978

V D Zhitar

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

V D Zhitar
[Hemostatic system in viral hepatitis. 3. Soluble fibrin monomer complexes and fibrinogen degradation products in patients with severe viral hepatitis].
August 1974, Polskie Archiwum Medycyny Wewnetrznej,
V D Zhitar
[Products of degradation of fibrinogen and their importance in hemostasis].
January 1965, Polskie Archiwum Medycyny Wewnetrznej,
V D Zhitar
The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
January 1967, Transactions of the Association of American Physicians,
V D Zhitar
Fibrinogen degradation products.
June 1971, The New England journal of medicine,
V D Zhitar
[Fibrinogen degradation products].
January 1998, Nihon rinsho. Japanese journal of clinical medicine,
V D Zhitar
Fibrinogen-fibrin degradation products.
January 1980, Annals of clinical and laboratory science,
V D Zhitar
Measurement of fibrinogen degradation products.
December 1970, The New England journal of medicine,
V D Zhitar
Fibrinogen, fibrinogen degradation products and erythrocyte flexibility.
October 1977, Thrombosis and haemostasis,
V D Zhitar
[Determination of fibrinogen/fibrin degradation products for diagnostic purposes in internal diseases].
June 1977, Polski tygodnik lekarski (Warsaw, Poland : 1960),
V D Zhitar
[Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
December 1993, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!